We first analyzed relative and absolute counts of circulating CD4+ and CD8+ T cells expressing PD-1 or TIM-3 in MM patients, divided into remission (complete remission (CR) and partial response (PR)) and progression groups. This evidence concerns the gene CD8A and Miyoshi myopathy.